Loading...
NYSE: ABBV
AbbVie Inc.
Healthcare · Drug Manufacturers - General
●S&P 500 since 2012
Market Cap
$368.38B
52w High
$244.81
52w Low
$164.39
P/E
87.77
Volume
6.94M
Outstanding Shares
1.77B
Company profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
CEORobert A. Michael
SectorHealthcare
IndustryDrug Manufacturers - General
Employees55,000
IPO dateJan 2, 2013
Valuation
Forward P/E—
EV/EBITDA16.72
Enterprise value$472.99B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth10.04%
Gross margin73.34%▲19.59%vs FY2024
Operating margin26.72%▲113.86%vs FY2024
ROE-129.24%▼200.45%vs FY2024
Analyst consensus
RatingBuy
Target price$256.15▲22.95%
26
Buy
12
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 24, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.97
$2.88
Q3FY25
ActualEst.
$1.86
$1.77
Q4FY25
ActualEst.
$2.71
$2.65
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$15.42B
$15.03B
Q3FY25
ActualEst.
$15.78B
$15.59B
Q4FY25
ActualEst.
$16.62B
$16.41B
Q1FY26
Next Est.
—